J. Henri Bayle

3.7k citations

25 papers · 3.0k indexed · 1 hit paper · h-index 19

Co-authors: Arnold J. LevineJun WuDavid C. Olson Kryn Stankunas Gerald R. Crabtree Jason E. Gestwicki Ching-Pin Chang Thomas J. Wandless
Topics: CAR-T cell therapy research (11 papers)Immune Cell Function and Interaction (5 papers)Signaling Pathways in Disease (5 papers)
Cited by: Oncology Biotechnology Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States France Canada

In The Last Decade

J. Henri Bayle

25 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The p53-mdm-2 autoregulatory feedback loop.

1993 1.5k citations Jun Wu, J. Henri Bayle et al. Genes & Development profile →

Peers

Countries citing papers authored by J. Henri Bayle

Since Specialization

Citations

This map shows the geographic impact of J. Henri Bayle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Henri Bayle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Henri Bayle more than expected).

Fields of papers citing papers by J. Henri Bayle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Henri Bayle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Henri Bayle. The network helps show where J. Henri Bayle may publish in the future.

Co-authorship network of co-authors of J. Henri Bayle

This figure shows the co-authorship network connecting the top 25 collaborators of J. Henri Bayle. A scholar is included among the top collaborators of J. Henri Bayle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Henri Bayle. J. Henri Bayle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial 2024 ·Nature Communications ·Mark N. Stein,Ecaterina E. Dumbrava,Benjamin A. Teply,Usama Gergis,(unknown),Ran Reshef,Sumit K. Subudhi,Céline Jacquemont,(unknown),J. Henri Bayle,Charity D. Scripture,(unknown),Mehmet Asım Bilen,Walter M. Stadler,Carlos Becerra	18
2	Preclinical Development of Inducible MyD88/CD40 (iMC)-Enhanced Chimeric Antigen Receptor Natural Killer (GoCAR-NK) Cells to Target BCMA+ Tumors 2020 ·Blood ·(unknown),MyLinh Duong,(unknown),Aruna Mahendravada,Kelly Sharp,Mary E. Brandt,Christine Gagliardi,Aaron E. Foster,J. Henri Bayle	1
3	Engineering Tolerance toward Allogeneic CAR-T Cells by Regulation of MHC Surface Expression with Human Herpes Virus-8 Proteins 2020 ·Molecular Therapy ·Xiaomei Wang,(unknown),Kelly Sharp,David M. Spencer,Aaron E. Foster,J. Henri Bayle	21
4	Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies 2019 ·Leukemia ·Matthew R. Collinson-Pautz,Wei-Chun Chang,An Lu,Mariam Khalil,(unknown),(unknown),Aruna Mahendravada,Nicholas Shinners,Mary E. Brandt,Ming Zhang,(unknown),J. Henri Bayle,Kevin M. Slawin,David M. Spencer,Aaron E. Foster	64
5	Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches 2018 ·Molecular Therapy — Oncolytics ·(unknown),Matthew R. Collinson-Pautz,Éva Morschl,An Lu,Sławomir Szymański,Ming Zhang,Mary E. Brandt,Wei-Chun Chang,Kelly Sharp,Steven M. Toler,Kevin M. Slawin,Aaron E. Foster,David M. Spencer,J. Henri Bayle	69
6	Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40 2017 ·Molecular Therapy ·Aaron E. Foster,Aruna Mahendravada,Nicholas Shinners,Wei-Chun Chang,(unknown),An Lu,Mariam Khalil,Éva Morschl,Joanne Shaw,(unknown),(unknown),Matthew R. Collinson-Pautz,David Torres,Tania Véliz Rodríguez,Tsvetelina Pentcheva‐Hoang,J. Henri Bayle,Kevin M. Slawin,David M. Spencer	93
7	Inducible MyD88/CD40 (iMC) Costimulation Provides Ligand-Dependent Tumor Eradication By CD123-Specific Chimeric Antigen Receptor T Cells 2016 ·Blood ·Aaron E. Foster,MyLinh Duong,An Lu,Peter S. Chang,Aruna Mahendravada,Nicholas Shinners,Kevin M. Slawin,J. Henri Bayle,David M. Spencer	2
8	Sudden Infant Death Syndrome in Mice With an Inherited Mutation in RyR2 2009 ·Circulation Arrhythmia and Electrophysiology ·Nitin Mathur,Subeena Sood,Sufen Wang,Ralph J. van Oort,Satyam Sarma,Na Li,Darlene G. Skapura,J. Henri Bayle,Miguel Valderrábano,Xander H.T. Wehrens	22
9	Endocardial Brg1 Represses ADAMTS1 to Maintain the Microenvironment for Myocardial Morphogenesis 2008 ·Developmental Cell ·Kryn Stankunas,Calvin T. Hang,(unknown),Hanying Chen,Nathan V. Lee,(unknown),Ching Shang,J. Henri Bayle,Weinian Shou,M. Luisa Iruela‐Arispe,Ching-Pin Chang	195
10	Rescue of Degradation‐Prone Mutants of the FK506‐Rapamycin Binding (FRB) Protein with Chemical Ligands 2007 ·ChemBioChem ·Kryn Stankunas,J. Henri Bayle,James J. Havranek,Thomas J. Wandless,David Baker,Robert H. Crabtree,Jason E. Gestwicki	26
11	Rapamycin Analogs with Differential Binding Specificity Permit Orthogonal Control of Protein Activity 2006 ·Chemistry & Biology ·J. Henri Bayle,Joshua S. Grimley,Kryn Stankunas,Jason E. Gestwicki,Thomas J. Wandless,Gerald R. Crabtree	161
12	A Field of Myocardial-Endocardial NFAT Signaling Underlies Heart Valve Morphogenesis 2004 ·Cell ·Ching-Pin Chang,Joel R. Neilson,J. Henri Bayle,Jason E. Gestwicki,Ann Kuo,Kryn Stankunas,Isabella A. Graef,Gerald R. Crabtree	265
13	Biochemical and Structural Basis for Partially Redundant Enzymatic and Transcriptional Functions of DCoH and DCoH2^, 2004 ·Biochemistry ·Robert B. Rose,(unknown),J. Henri Bayle,Robert H. Crabtree,Tom Alber	19
14	Conditional Protein Alleles Using Knockin Mice and a Chemical Inducer of Dimerization 2003 ·Molecular Cell ·Kryn Stankunas,J. Henri Bayle,Jason E. Gestwicki,Yun‐Ming Lin,Thomas J. Wandless,Gerald R. Crabtree	110
15	Hyperphenylalaninemia and Impaired Glucose Tolerance in Mice Lacking the Bifunctional DCoH Gene 2002 ·Journal of Biological Chemistry ·J. Henri Bayle,Filippo Randazzo,Georg Johnen,Seymour Kaufman,András Nagy,Janet Rossant,Gerald R. Crabtree	19
16	Structural basis of dimerization, coactivator recognition and MODY3 mutations in HNF-1alpha. 2000 ·Nature Structural Biology ·Tom Alber,Robert B. Rose,J. Henri Bayle,James A. Endrizzi,(unknown),(unknown)	36
17	Protein acetylation: more than chromatin modification to regulate transcription 1997 ·Chemistry & Biology ·J. Henri Bayle,Gerald R. Crabtree	25
18	Alternatively Spliced Forms in the Carboxy-Terminal Domain of the p53 Protein Regulate Its Ability to Promote Annealing of Complementary Single Strands of Nucleic Acids 1995 ·Molecular and Cellular Biology ·Lin Wu,J. Henri Bayle,Brian Elenbaas,Nikola P. Pavletich,Arnold J. Levine	99
19	The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity. 1995 ·Proceedings of the National Academy of Sciences ·J. Henri Bayle,Brian Elenbaas,Arnold J. Levine	89
20	The p53-mdm-2 autoregulatory feedback loop.breakdown → 1993 ·Genes & Development ·Jun Wu,J. Henri Bayle,David C. Olson,Arnold J. Levine	1506

About J. Henri Bayle

J. Henri Bayle is a scholar working on Oncology, Immunology and Developmental Neuroscience, having authored 25 papers that have together received 3.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (5 papers) and Signaling Pathways in Disease (5 papers). The work is most often cited by research in Oncology (1.8k citations), Biotechnology (426 citations) and Molecular Biology (2.2k citations). J. Henri Bayle has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Arnold J. Levine, Jun Wu, David C. Olson, Kryn Stankunas, Gerald R. Crabtree, Jason E. Gestwicki, Ching-Pin Chang, Thomas J. Wandless, Brian Elenbaas and Isabella A. Graef. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact